Dr. Wan C. Tan

Dr. Wan C Tan is a Respirologist in the Department of Medicine, University of British Columbia, BC, Canada and the Division of Respiratory Medicine, St Paul’s Hospital, Vancouver, BC, Canada. Dr Tan has long standing involvement with global management guidelines for asthma and COPD and is an author of over 200 publications in peer-reviewed journals. She is the Co-Principal Investigator for the longitudinal CanCOLD [Canadian Cohort of Obstructive Lung Disease] Study, for measuring and phenotyping COPD in the community.

Dr. Brandie Laurel Walker

Dr. Walker is a Clinical Associate Professor in the Division of Respirology at the University of Calgary and is the Respirology site lead at the Foothills Medical Centre. Her clinical practice and research focus is airways disease. She is the program director for the Severe Asthma Fellowship Program at the University of Calgary, Medical Director of the Severe Asthma Clinic and Calgary COPD and Asthma Program, and runs a multidisciplinary Severe COPD clinic.

Dr. Darcy D. Marciniuk

MD, FRCPC, FCAHS, Master FCCP

CanCOLD Saskatoon site investigator and Chair of the Knowledge Translation and Dissemination Committee

Darcy D. Marciniuk, MD, FRCPC, FCAHS, Master FCCP is a Professor of Respirology, Critical Care and Sleep Medicine, and Associate Vice-President Research at the University of Saskatchewan, Saskatoon, SK, Canada. Dr. Marciniuk serves as Deputy Editor – Outreach for the journal CHEST, is a past-President of CHEST and the Canadian Thoracic Society, past-Chair of the Forum of International Respiratory Societies (FIRS) and was a founding Steering Committee member of Canada’s National Lung Health Framework.

Dr. Francois Maltais

MD FRCPC

CanCOLD Quebec City site investigator and Chair of the Substudy and Ancillary Study (SAS) Committee

Doctor Maltais is director of the Department of pulmonology and thoracic surgery at the Quebec Heart and Lung Institute and professor at the Faculté de médecine de l’Université Laval. His major interests include the physiopathology of exercise intolerance in chronic obstructive pulmonary disease (COPD) and pulmonary rehabilitation. His researches, which are supported by the Canadian Institutes of Health Research (CIHR), Canada’s premier funding agency for health research, also focus towards the understanding of the mechanism of limb muscle dysfunction in COPD. He became in 2009, the director of the Research Chair on COPD at Université Laval.

Dr. Shawn Aaron

Dr. Shawn Aaron is a Professor in The Department of Medicine at the University of Ottawa and a Senior Scientist at the Ottawa Hospital Research Institute. He is a respirologist at the Ottawa Hospital. Dr. Aaron conducts clinical and health services research focused on 3 respiratory diseases: COPD, asthma and cystic fibrosis. Dr. Aaron leads the Canadian Respiratory Research Network, a Canadian airway disease research network.

Dr. Jean Bourbeau

Dr Jean Bourbeau is a Professor, Department of Medicine, and associate member of the Department of Epidemiology, Biostatistics and Occupational Health, at McGill University. He is a Respirologist at the Montreal Chest Institute of the McGill University Health Centre (MUHC), the Director of the Montreal Chest Institute’s COPD clinic and pulmonary rehabilitation program and the Director of the Center of Innovative Medicine (CIM) at the Research Institute of the MUHC. He has been devoted to COPD research since the 1990s. His research focuses on epidemiology and outcomes of COPD using different methodological approaches, which has led to the creation of the Canadian Cohort of Obstructive Lung Disease (CanCOLD) and an integrated mode of treatment, Living Well with COPD (LWWCOPD) self-management program, combining pharmacologic and lifestyle changes that is innovative in directly involving patients as partners in their own care.

Dr. Kenneth R. Chapman

Dr. Chapman is Director of the Asthma and Airway Centre of the University Health Network, President of the Canadian Network for Respiratory Care and Director of the Canadian Registry for Alpha-1 Antitrypsin Deficiency. A Professor of Medicine at the University of Toronto, Dr. Chapman is an internationally respected researcher and lecturer in the fields of asthma and COPD. With more that 20,000 citations to his published work, he is in the top 1% of cited medical researchers.

Dr. Denis E. O’Donnell

Dr. Denis O’Donnell is a Professor of Medicine at Queen’s University, Kingston, Ontario with cross appointments to the Departments of Biomedical & Molecular Sciences (Physiology), Rehabilitation Medicine and Kinesiology & Health Studies. He is a Senior Clinician Scientist and Director of the Respiratory Investigation Unit, Kingston Health Science Centre. Dr. O’Donnell’s research is primarily focused on clinical integrative physiology including the physiological mechanisms of dyspnea and exercise limitation across the severity spectrum of chronic obstructive pulmonary disease.

Dr. Paul Hernandez

Dr. Paul Hernandez is a Respirologist and Head/Chief, Division of Respirology (Central Zone, Nova Scotia Health), Medical Director of the Pulmonary Rehabilitation Program and medical co-lead of the 3-Intermediate Care Unit at the QEII Health Sciences Centre. He is a Professor of Medicine in the Faculty of Medicine at Dalhousie University in Halifax, Nova Scotia, Canada. Dr. Hernandez is president of the Canadian Thoracic Society (CTS), past chair of the Adult Respirology Examination Board of the Royal College of Physicians and Surgeons of Canada, and past chair of the CTS COPD Clinical Assembly. His main clinical and research areas of interest are COPD, asthma, pulmonary rehabilitation, and pulmonary hypertension.